Keys To Handling Digital Investigations In Pharma IP Litigation
Across global pharmaceutical markets, disputes over patents, intellectual property and go-to-market strategies have persisted for decades between large pharmaceutical companies and generics manufacturers. These disputes are often expensive and time-intensive, and...To view the full article, register now.
Already a subscriber? Click here to view full article